Sign in

CBPHF on OTC

Clover Biopharmaceuticals, Ltd.

Clover Biopharmaceuticals, Ltd. is a biotechnology company that raised $53.4 million in 2026 (SEC Form D).1 It is headquartered in Chengdu, China.1 Its shares trade on OTC under the symbol CBPHF.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

  • TickerCBPHF on OTC1
  • HeadquartersChengdu, China1
  • Incorporated inCayman Islands2
  • Business addressB5-19,Building,High-Tech Incubation Park, No. 1480 North Section Of Tianfu Avenue, Chengdu, F4 6100412
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorJoshua Liang named May 9, 2023 to Apr 29, 20263
  • Executive Officer, Director, PromoterPeng Liang named May 9, 2023 to Apr 29, 20263
  • DirectorXiaodong Wang named May 9, 2023 to Apr 29, 20263

Filings

5 filings to the SEC since October 2021: 5 private raises. The latest 5:

  1. Apr 29, 2026D EDGAR
  2. Apr 28, 2025D/A EDGAR
  3. Apr 12, 2024D EDGAR
  4. May 9, 2023D/A EDGAR
  5. May 24, 2022D/A EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$53.4M 2021–2026
Money received by yearMoney received by year, 2021–2026: $53.4M in all. Private raises (Form D) $53.4M.$0$20M$40M$60M2021 · Private raises (Form D): $48.9M202120232024 · Private raises (Form D): $904.9K20252026 · Private raises (Form D): $3.6M2026
Figures by year
YearPrivate raises (Form D)Total
2026$3.6M$3.6M
2024$904.9K$904.9K
2021$48.9M$48.9M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Mar 27, 2026Raised $3.6 million in a private offering of equity3 Form D: 9 investors so far Form D
  2. Apr 2, 2024Raised $904,859 in a private offering of equity4 Form D: 13 investors so far Form D
  3. Apr 18, 2021Raised $48.9 million in a private offering of equity5 Form D: 74 investors so far Form D

SEC filer profile

How Clover Biopharmaceuticals, Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARClover Biopharmaceuticals, Ltd.1
  • CIK0001856491
  • Incorporated inCayman Islands1
  • Fiscal year endsDecember 311
  • Business addressB5-19,Building,High-Tech Incubation Park, No. 1480 North Section Of Tianfu Avenue, Chengdu, F4 6100411
  • Phone0086-28-8533-69661
  • On EDGAR sinceApr 28, 20211
  • Filings6 in all: D (3), D/A (3)1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5